All companies
Visit website
TTC ONCOLOGY
OperatingTTC Oncology, LLC
Technology · Founded 2015
Developed TTC-352, a small molecule to fight breast cancer
Valuation cap ⓘ
$25.0M
As of Apr 2023 · from TTC ONCOLOGY Future Equity SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$141,830
Across 1 round since 2021
Financials
FY2019–FY2020 · from SEC filings · hover any figure for its source$0
−$1.2M
2019
$0
−$100K
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$1,207,239
-$99,617
Taxes paid
$0
$0
Balance sheet
Cash
$87,628
$117,558
Accounts receivable
$0
$0
Total assets
$485,956
$486,339
Short-term debt
$0
$0
Long-term debt
$408,446
$408,446
Total liabilities
$408,446
$408,446
Other
Headcount
—
1
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$25.0M
Valuation cap
TTC ONCOLOGY Future Equity SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $141.8K / $1MInvestors 73Valuation cap $25M
Reg CF annual-report compliance
Delinquent
Filed 0 of 5 annual reports (FY2021–FY2025)
Missing: 2021, 2022, 2023, 2024, 2025
73 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001889745
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.